Clinical Trials Directory

Trials / Terminated

TerminatedNCT01874730

KOREAN Enhanced RecOvery Strategy for Colorectal Surgery

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
101 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
45 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This is a multi-centre study to take place in approximately 3 centers in Seoul, South Korea. The study will be carried out as a prospective, randomized, controlled, multicenter, clinical trial in patients undergoing colorectal surgery. The purpose of this study is to determine if an enhanced recovery strategy paying close attention to the type and amount of fluid given during the surgery with proper monitoring combined with a comprehensive perioperative pain management will have a better post-operative outcome compared to institutional standard of care (SOC), in patients undergoing surgery of the colon. One of the fluids used, Volulyte®, is an intravenous solution used to treat low blood volume. The Volulyte® solution being used in the study and the monitor used are approved by the Korean Food and Drug Administration

Conditions

Interventions

TypeNameDescription
OTHERCombined epidural-general anesthesia (CEGA)Combined epidural-general anesthesia (CEGA) will be used intraoperatively and patient-controlled epidural analgesia (PCEA) will be used postoperatively in a multimodal analgesic regimen.
DRUGVolulyte® (6% HES 130/0.4 in balanced solution)For the SOC Group: Intraoperative fluid management includes Volulyte® (6% HES 130/0.4 in balanced solution) as the only colloid solution to be used, the daily dosage of Volulyte® is restricted to 50 ml/kg. For the ERS Group: GDFT regimen will be utilized using Volulyte® (6% HES 130/0.4 in balanced solution) during surgery. The daily dosage of Volulyte® is restricted to 50 ml/kg.
OTHERPatient-Controlled Epidural Analgesia (PCEA)For the ERS Group, patient-controlled epidural analgesia (PCEA) will be used postoperatively in a multimodal analgesic regimen.

Timeline

Start date
2013-07-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2013-06-11
Last updated
2015-08-07

Locations

3 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01874730. Inclusion in this directory is not an endorsement.